"Others have expressed similar unease. In 2020, Dr. Joanna Hellmuth, then a neurologist at the University of California, San Francisco, published an article in The Lancet Neurology pointing to a number of “red flags” within Mr. Bredesen’s studies, including “the substantial potential for a placebo effect.” Dr. Jason Karlawish, the co-director of Penn Memory Center at the University of Pennsylvania, said Mr. Bredesen’s research and recommendations don’t adhere to the standards of medicine. The Alzheimer Society of Canada has gone so far as to say Mr. Bredesen is offering “false hope.”- New York Times
PARC's Jason Karlawish offers insight into the NYT's investigation of a popular treatment for the reversal of Alzheimer's symptoms.
Citation: " An Expensive Alzheimer’s Lifestyle Plan Offers False Hope, Experts Say," The New York Times, L Gellman, May 21, 2025.